| Previous close | 26.90 |
| Open | 27.05 |
| Bid | 21.00 |
| Ask | 23.80 |
| Strike | 85.00 |
| Expiry date | 2026-01-16 |
| Day's range | 26.90 - 26.90 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- GuruFocus.com
Sarepta Therapeutics Inc (SRPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
Discover key insights from Sarepta Therapeutics' Q1 2024 earnings, including significant revenue increases and promising developments in drug approvals and market expansions.
ZacksSarepta Therapeutics (SRPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Sarepta Therapeutics (SRPT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ZacksSarepta Therapeutics (SRPT) Q1 Earnings and Revenues Beat Estimates
Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of 763.64% and 10.91%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.